ATI Physical Therapy Price to Sales Ratio 2020-2023 | ATIP
Historical PS ratio values for ATI Physical Therapy (ATIP) over the last 10 years. The current P/S ratio for ATI Physical Therapy as of April 29, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ATI Physical Therapy P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-29 | 4.17 | 0.02 | |
| 2023-12-31 | 6.14 | $169.37 | 0.04 |
| 2023-09-30 | 8.86 | $165.07 | 0.05 |
| 2023-06-30 | 9.15 | $160.73 | 0.06 |
| 2023-03-31 | 12.71 | $158.97 | 0.08 |
| 2022-12-31 | 15.25 | $156.70 | 0.10 |
| 2022-09-30 | 50.00 | $163.86 | 0.31 |
| 2022-06-30 | 70.50 | $165.84 | 0.43 |
| 2022-03-31 | 94.00 | $184.56 | 0.51 |
| 2021-12-31 | 169.50 | $204.20 | 0.83 |
| 2021-09-30 | 190.00 | $157.23 | 1.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.018B | $0.699B |
| ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.392B | 9.92 |
| Quest Diagnostics (DGX) | United States | $14.915B | 15.41 |
| DaVita (DVA) | United States | $11.709B | 15.93 |
| Chemed (CHE) | United States | $8.472B | 26.30 |
| Encompass Health (EHC) | United States | $8.259B | 21.25 |
| Elanco Animal Health (ELAN) | United States | $6.552B | 14.90 |
| Option Care Health (OPCH) | United States | $5.147B | 19.48 |
| RadNet (RDNT) | United States | $3.314B | 96.80 |
| Amedisys (AMED) | United States | $2.999B | 21.25 |
| LifeStance Health (LFST) | United States | $2.370B | 0.00 |
| Astrana Health (ASTH) | United States | $2.057B | 25.68 |
| Addus HomeCare (ADUS) | United States | $1.548B | 23.52 |
| U.S Physical Therapy (USPH) | United States | $1.516B | 39.30 |
| Pennant (PNTG) | United States | $0.624B | 36.46 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.423B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.323B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.014B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.005B | 0.00 |